The degree of formality in a risk management process should be customized to the organization’s particular needs and the risks involved.
Darshana Patel
Advertisement
Darshana Patel is an associate director in Global Quality at Merck & Co., Inc.
Articles by Darshana Patel
Advertisement
Latest Updated Articles
Navigating the Formality Spectrum in ICH Q9(R1)July 2nd 2023
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
PharmTech Weekly Roundup—June 19, 2026
4
Why the First Generic Single-Dose Flu Antiviral Approval Matters
5